Orforglipron vs Dulaglutide for Type 2 Diabetes
(ACHIEVE-PEDS Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This study looks at how well a medicine called orforglipron works compared to another medicine called dulaglutide in pediatric participants aged 10 to less than 18 years with type 2 diabetes. The study will also check how safe these medicines are and how the body processes them.
Participation in the study will last about 61 weeks.
Who Is on the Research Team?
Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 8 AM - 8 PM Eastern time (UTC/GMT - 5 hours, EST)
Principal Investigator
Eli Lilly and Company
Are You a Good Fit for This Trial?
This trial is for children and teens aged 10 to under 18 years who have type 2 diabetes. Participants should be otherwise healthy enough to take part, as determined by the study team.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either orforglipron orally or dulaglutide subcutaneously
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Trial Overview
The study compares two medicines—Orforglipron (a new oral drug) and Dulaglutide (an injectable medicine)—to see which works better and is safer for treating type 2 diabetes in young people over about a year.
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Active Control
Participants will receive orforglipron orally
Participants will receive dulaglutide subcutaneously (SC)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Eli Lilly and Company
Lead Sponsor
Dr. Daniel Skovronsky
Eli Lilly and Company
Chief Medical Officer since 2018
MD from Harvard Medical School
David A. Ricks
Eli Lilly and Company
Chief Executive Officer since 2017
BSc from Purdue University, MBA from Indiana University
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.